Asia-Pacific Next Generation Sequencing Market Set to Soar to $6.38 Billion by 2030
Meticulous Research®– a leading global market research company, published a research report titled "Asia-Pacific Next Generation Sequencing (NGS) Market by Offering (Kits [Library Prep, QC, DNA Extraction], System) Type (Genome, Exome, Targeted) Application (Reproductive, Oncology) Technology (SBS, Nanopore, Nanoball, SMRT Seq) – Forecast to 2030. "
Download Free Sample Report@ https://www.meticulousresearch.com/download-sample-report/cp_id=5722?utm_source=pdf&utm_medium=social&utm_campaign=product&utm_content=29-05-2024
Meticulous
Research®, a premier market intelligence firm, has unveiled an exhaustive
report forecasting substantial growth in the Asia-Pacific Next Generation
Sequencing (NGS) Market. Projected to grow at a compound annual growth rate
(CAGR) of 16.9%, the market is expected to reach a valuation of $6.38 billion
by 2030. This remarkable expansion is driven by several key factors, including
the rising prevalence of cancer, increased application of NGS in cancer
treatment and research, declining costs of genome sequencing, technological
advancements in sequencing procedures, and growing pharmaceutical R&D
expenditures.
Driving
Factors and Market Dynamics
The
burgeoning NGS market in Asia-Pacific is fueled by a multitude of factors:
Rising
Cancer Prevalence: Increased application of NGS in cancer treatment and
research is significantly contributing to market growth.Technological
Advancements: Innovations in sequencing procedures are making NGS more
accessible and efficient.Cost Decline: The decreasing costs associated with
genome sequencing are making these technologies more affordable.
Pharmaceutical
R&D: Growing investments in pharmaceutical research and development are
boosting the adoption of NGS technologies.
However,
the market faces challenges such as the high costs of NGS systems and
consumables and the availability of alternative technologies. Despite these
hurdles, opportunities abound with the increasing applications of NGS, rising
adoption of bioinformatics and genomic data management solutions, and
government initiatives supporting large-scale genomic sequencing projects.
Nonetheless, the lack of skilled professionals and regulatory and
standardization concerns in diagnostic testing present significant challenges
to market growth.
Key
Market Segments and Insights
Offering
Segment: The consumables segment is expected to dominate the market, driven by
the recurring use of consumables, rising demand for NGS-based diagnostic tests,
and increasing applications in oncology, reproductive health diagnosis, and
drug discovery.Technology Segment: Sequencing by synthesis is projected to lead
the market due to its high accuracy, error-free throughput, and widespread
incorporation in NGS products.
Application
Segment: The research and other applications segment is anticipated to command
the largest share, fueled by the prevalence of genetic disorders, increasing
adoption of sequencing-based tests, and growing demand for personalized
medicines.
End
User Segment: Pharmaceutical and biotechnology companies are expected to be the
leading end-users, owing to increased R&D spending and the rising incidence
of chronic diseases.
Regional
Outlook
Geographically,
China is poised to dominate the Asia-Pacific NGS market by 2030. This growth is
attributed to favorable government initiatives for genomics research, expanding
applications of NGS-based research, rising awareness of NGS-based tests, and increasing
prevalence of cancer and genetic diseases.
Competitive
Landscape
Prominent
players in the Asia-Pacific NGS market include: Thermo Fisher Scientific Inc.
(U.S.)Illumina, Inc. (U.S.)Qiagen N.V. (Netherlands)F. Hoffmann-La Roche Ltd
(Switzerland)PerkinElmer, Inc. (U.S.)Agilent Technologies, Inc. (U.S.)Pacific
Biosciences of California Inc. (U.S.)Danaher Corporation (U.S.)Bio-Rad
Laboratories, Inc. (U.S.)Oxford Nanopore Technologies Plc. (U.K.)10X Genomics,
Inc. (U.S.)
Conclusion
The
Asia-Pacific Next Generation Sequencing (NGS) market is on a robust growth
trajectory, driven by technological advancements, increasing cancer prevalence,
and growing pharmaceutical R&D activities. Despite facing challenges such
as high costs and regulatory concerns, the market presents significant
opportunities for growth, particularly with the rise of bioinformatics and
government-backed genomic projects. As key players continue to innovate and
expand, the NGS market in Asia-Pacific is set to reach new heights,
transforming the landscape of medical research and diagnostics.
About Meticulous
Research®:
Meticulous Research® was founded
in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a
private limited company under the Companies Act, 1956. Since its incorporation,
the company has become the leading provider of premium market intelligence in
North America, Europe, Asia-Pacific, Latin America, and the Middle East &
Africa.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment